Filter Results:
(54)
Show Results For
- All HBS Web
(637)
- People (2)
- News (54)
- Research (448)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Show Results For
- All HBS Web
(637)
- People (2)
- News (54)
- Research (448)
- Events (2)
- Multimedia (8)
- Faculty Publications (395)
Page 1 of 54
Results →
Sort by
- 07 Apr 2016
- News
Sanofi Genzyme Donates Corporate Archives to Harvard Business School
- 03 Aug 2010
- News
Analysis: Rare diseases lure Sanofi, other big drugmakers
- 04 Jun 2010
- News
Another View: Can Biotech Survive Icahn?
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 03 Dec 2012
- News
In World of Big Stuff, the U.S. Still Rules
- 08 Jan 2018
- News
What Do Investors and Companies Talk About?
- 01 Aug 1998
- News
High Honors
education." McDermott hasn't slowed down in retirement, concentrating his energy and vision on an array of community-related projects. Among them is the Texas Research and Technology Foundation, which he established in 1984 to develop San Antonio's Texas Research Park,... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
focused on patients. “Patients and their families are at the center of why I want to be in the biotechnology space,” she concludes. “When you’re working on rare diseases, it’s hard not to feel like you’re making a difference.” View Details
- 31 Jan 2014
- News
Body, Heal Thyself
Chien and Derrick Rossi, published a paper in the journal Nature Biotechnology that showed mRNA Therapeutics was capable of stimulating blood vessel growth, repairing damaged heart tissue, and helping a mouse through myocardial... View Details
- 01 Apr 2000
- News
Porter's Paradox
decisive, enduring advantages, therefore, become unique local centers of innovation for the likes of mutual funds, venture capital, and biotechnology in Greater Boston or aircraft equipment and design, boat- and shipbuilding, and metal... View Details
- 01 Jun 2016
- News
@Soldiers Field
diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A... View Details
- 13 Feb 2023
- News
Alumnus Gift Will Nurture Basic, Therapeutic Science
been a partner of the School for over two decades, and I am delighted to continue to support the HMS community in its important work by helping to modernize these landmark facilities to keep pace with therapeutics innovation." Bertarelli is a former View Details
- 01 Dec 2006
- News
Faculty Books
reveal the mechanisms of advancement and speculate on what this means for the future of leadership selection and development. Science Business by Gary P. Pisano (HBS Press) Why has the biotechnology industry failed to perform to... View Details
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift... View Details
Keywords: Anne Kavanagh
- 01 Mar 2004
- News
The Business of Babies
surrogate mother have the right to change her mind and keep the baby she’s carrying?) and the political climate becomes more accepting of the role science can play in creation (with cloning the most radical example), the market cannot thrive. “If advances in View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 01 Jun 2000
- News
The Right Connections
resources -- what we call social capital." Organizational behaviorists have known for years that third-party endorsements are critical to a young firm's success. Higgins and Gulati wanted to understand the origins and nature of these important relationships. They... View Details
Keywords: Judith A. Ross
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He... View Details